Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...

News from the week beginning 3rd November includes items from @1111Systems, @CybageSoftware, @Deltek, @Expereo, @Epicor, @Ultimo, @Percona, @Planful, @Quantexa and @Quantware ...